And the days to cover on the Naz site because volume has dried up the last week or ten days. Good news and shorts will be reaching for the KY jelly
Doesn't matter much what revenues are when you give your product away. Maybe they should sell more quarter so they can lose more money?
*Recent Medicare reimbursement changes are benefitting MDXG
** MDXG has entered a US distribution agreement with Medtronic's spine business..expects sales to begin to ramp after MDT's June spine sales meeting when it intends to introduce the product to its sales force. We believe that sales to Medtronic are a source of potential upside to estimates.
*MDXG's gross margin is very high and we expect profitability to ramp quickly as revenue outpaces operating expenses. Current GM in the mid 80s and is among the highest in the med tech sector. We believe it can reach a 17% operating margin in 2016 with revenue of around $200M.
*Combined opportunity of $13 billion. Wound care, surgical and sports med $2.5B, tendinopathy and pain management $7.5B and surgical barrier and scar prevention market is $3 billion.
*Outlook- In our model, we have revenue growing at a 50% CAGR from 2013 through 2016, with wound care revenue growing by a 71% CAGR and surgical, sports medicine & OEM growing by a 13% CAGR. However, we believe our estimates are likely to prove conservative (particularly for wound care) and we see potential for MiMedx's revenue CAGR to significantly exceed our estimates.
What are the price targets from analysts covering OSIR? Oh yeah, they can't get anyone to cover them. Wonder why?
Very thorough 25 page note. Pouring through it now.Price target is low but the good analysts today stay away from the silly price targets. Beware of analysts who come out with buy recs and $25 targets on $10 stocks. That's just silly and 9 times out of 10 you end up with mud on your eye. Looking for some more good names to cover in the near future. I wonder why OSIR isn't getting any coverage? (Sarcasm).
What kills candyass is that he knows Doc, old_wisetrader, me and the other long time longs here are accredited investors ( something candyass will never be since it requires a specific net worth) who were in on the pipe or around that time under a buck and it kills him that we are sitting on a 7 banger which will be a 15-20 banger some time in 2015 while he worries month to month how he will be able to pay his rent on his little apartment and make the car payment on his Ford Focus.
Glassman, I am an attorney and finance guy and I agree with you complete. I have many doctor friends and though fine doctors, most tend to be poor business people and clueless when it comes to finances and investing in particular.. Always exceptions like one of the docs on this board. Just speaking in general terms.
ozark, "slight problem" with your numbers. You see, most Grafix sales do not come from OSIR employees but from distributors.
Oh, we understand the science. So do doctors and hospitals are choosing EpiFix and why its kicking Grafix's #$%$. Wait to see the second half of the year. It will get even worse for you.
freebeer ,guess your name says it all. Funny how blind longs when faced with indisputable FACTS simply reply "I'm an Oz backer". old wise trader presented 100% fact (ask for the details of the study if you don't believe him) of the patients included in the study. You can doubt it all you want but its fact. And, its fact that they included patients that would have healed on their own while MDXG included only hard to heal patients. The truth sometimes hurts but the truth will set you free, free from thew wrong stock in OSIR in this case. Don't blindly follow a message board poster. Educate yourself
Good stuff from old_wisetrader from OSIR board
Ozark, don't shoot the messenger, someone very knowledgeable with the wound care business has asked me to provide you with some facts regarding your conversation on studies.
I’m not too sure about the Grafix ‘high quality trial’ that you mentioned. Yes, they had 90 some people, and it had purported good results. Frankly, they should have – the population in the study had wounds that most likely would have healed on their own. Anyone who has been around wound care knows about the Sheehan study from back in 2003 that basically proved the trajectory of wounds that heal on their own with conservative therapy vs. those which need advanced therapies. This study is the basis for reimbursement and treatments in wound care and has been so for a decade or more. This basically said that if a wound area is reduced by 12.5% or more in a week, 25% or more in 2 weeks, or 50% or more in 4 weeks, it will likely go on to heal without any advanced therapy interventions. Now to the Grafix study – they allowed DFU’s with wound area reduction up to 30% in ONE week to be in the study! These are the easy to heal wounds! The EpiFix studies excluded anyone who healed more than 20% in TWO weeks, so their wounds were harder to heal. Also Ozark – you mentioned the demographics in the first EpiFix study, but you failed to mention that they did a cross-over study with the control patients and they healed at 90+% in about 8 weeks, so your argument does not hold water. Plus the 40 patients in the 1 week vs. 2 week EpiFix study with a 90% healing rate.
cezassee, ask RG3 and Adrienne Peterson how that "sanka" is working for them as well as the other professional athletes Dr. James Andrews is using AmnioFix on. Hey, when is that SEC crackdown on Pete Petit coming? Oh yeah, it's over. And how about your FDA prediction of AmnioFix getting pulled? When is that happening? Oh wait, that isn't happening either. There's only one bad surprise coming and guess what, it isn't coming to MDXG but to OSIR.
Ahhh, a walk down memory lane. Prior posts by cezasse9
cezasse9 • May 20, 2014 2:52 PM
Poor Pete - always in trouble with the authorities.
cezasse9 • May 20, 2014 3:30 PM
SEC, FDA, BBB, ugh - who's next....
cezasse9 • May 20, 2014 9:21 PM
Halloween Candy - I like the way you think. It's about the SEC and FDA coming down hard on a SMUG Petit. Play with FIRE and get BURNED.
cezasse9 • May 21, 2014 12:58 PM Flag
Candyman - thanks for the heads up on this PIG. I'm shorting away and I will cover after the SEC and FDA tag team Poor Old Pete.... hehehehehehe
(By the way stock was about $5.41 on this date. Having fun cezasse9?)
And, remember this classic when cesasse9 thought the term states evidence applied in a civil trial? LOL. What an idiot. You are just a wealth of brilliant predictions. No doubt you are a complete failure in life.
cezasse9 • May 23, 2014 3:52 PM
Candyman - great day to short - - - WINK, WINK. Poor old Pete - just wait till Arrowood turns state's evidence. Gonna hurt for the MDXG faithful that day for sure.